Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma

被引:0
|
作者
Hu, Wei [1 ,2 ,3 ]
Klumper, Niklas [1 ]
Schmidt, Doris [1 ]
Ritter, Manuel [1 ]
Ellinger, Jorg [1 ]
Hauser, Stefan [1 ,4 ]
机构
[1] Univ Hosp Bonn, Dept Urol, Bonn, Germany
[2] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Hubei, Peoples R China
[3] Wuhan Univ, Renmin Hosp, Dept Urol, Jiefang Rd 238, Wuhan 430060, Hubei, Peoples R China
[4] Univ klinikum Bonn, Klinik & Poliklin Urol & Kinderurol, Bonn, Germany
来源
关键词
m6A-erasers; clear cell renal cell carcinoma (ccRCC); epithelial-mesenchymal transition (EMT); FTO; ALKBH5; DNA METHYLATION ANALYSIS; RNA; EXPRESSION; ERASERS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: N6-methyladenosine (m6A) is one of the most common RNA modifications in eukaryotes and has effects on RNA structure and stability. Recent studies have shown that m6A methylation is involved in human carcinogenesis. In the present study, we investigated the effects of m6A demethylases FTO and ALKBH5 on renal cell carcinoma (RCC) cell lines. Methods: The epithelial-mesenchymal in vitro knockdowns of FTO and ALKBH5 induced by antisense oligonucleotides (LNA-GapmeR system) were established in RCC cell lines. Their effects on migration and proliferation were investigated subsequently. The influence of FTO and ALKBH5 knockdown on key epithelialmesenchymal transition (EMT) genes was analyzed. Results: Inactivation of FTO and ALKBH5 resulted in decreased proliferation and motility in all cell lines examined (ACHN, Caki-1, 769-P). Vimentin (VIM) was downregulated after the knockdown of FTO and ALKBH5, indicating an EMT switch. Conclusions: Knockdown of the m6A erasers FTO and ALKBH5 inhibits the malignant potential in the cell cultures studied by means of an EMT switch.
引用
收藏
页码:1744 / +
页数:14
相关论文
共 50 条
  • [31] Molecular subtypes of m6A RNA methylation modification patterns and their clinical significance in clear cell renal cell carcinoma
    Guan, Bo
    Ren, Feng
    Shan, Weimin
    Zhang, Shangrong
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (03) : 508 - 518
  • [32] ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m6A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype
    Yu, Tingting
    Yao, Lan
    Yin, Hua
    Teng, Yao
    Hong, Mei
    Wu, Qiuling
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (06): : 2235 - 2248
  • [33] Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma
    Wang, Jiawu
    Zhang, Chengyao
    He, Weiyang
    Gou, Xin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [34] Deubiquitinase USP9X stabilizes RNA m6A demethylase ALKBH5 and promotes acute myeloid leukemia cell survival
    Wang, Peipei
    Wang, Jing
    Yao, Shuxin
    Cui, Manman
    Cheng, Ying
    Liu, Weidong
    Gao, Zhuying
    Hu, Jin
    Zhang, Jinfang
    Zhang, Haojian
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (08)
  • [35] N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis
    Zhuang, Changshui
    Zhuang, Chengle
    Luo, Xiaomin
    Huang, Xinbo
    Yao, Lv
    Li, Jianfa
    Li, Yawen
    Xiong, Tiefu
    Ye, Jing
    Zhang, Fangting
    Gui, Yaoting
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (03) : 2163 - 2173
  • [36] Comprehensive Evaluation of the m6A Regulator Prognostic Risk Score in the Prediction of Immunotherapy Response in Clear Cell Renal Cell Carcinoma
    Yu, Mingke
    Liu, Xuefei
    Xu, Han
    Shen, Sangyu
    Wang, Fajiu
    Chen, Dajin
    Li, Guorong
    Wang, Zongping
    Zuo, Zhixiang
    Zhao, An
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] m6A RNA modification modulates gene expression and cancer-related pathways in clear cell renal cell carcinoma
    Chen, Yimeng
    Zhou, Cuixing
    Sun, Yangyang
    He, Xiaozhou
    Xue, Dong
    EPIGENOMICS, 2020, 12 (02) : 87 - 99
  • [38] Predictive value of m6A regulators in prognosis and immunotherapy response of clear cell renal cell carcinoma: a bioinformatics and radiomics analysis
    Chen, Wanqi
    Lin, Tuanyu
    Wang, Zhenshan
    Zeng, Liting
    Lin, Haitao
    Yang, Guisheng
    Huang, Weipeng
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2024, 10
  • [39] Molecular Characterization of m6A Modifications in Non-Clear Cell Renal Cell Carcinoma and Potential Relationship with Pathological Types
    Xiang, Xuebao
    Guo, Yi
    Chen, Zhongyuan
    Mo, Zengnan
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 1595 - 1608
  • [40] m6A-related genes ALKBH5 and RBMX as prognostic and progression biomarkers in Chinese oral squamous cell carcinoma patients
    Liu, Yong
    Nie, Jiaying
    Huang, Ying
    Yang, Yunyan
    Su, Wenen
    Zhang, Yumei
    Gao, Zhuoqiao
    Deng, Shaohui
    Li, Meilin
    Lian, Shaoyan
    Li, Jieying
    Liu, Chaoqun
    ARCHIVES OF ORAL BIOLOGY, 2025, 170